Literature DB >> 9058288

Clinical trial of prophylactic endoscopic variceal ligation for esophageal varices.

H Kishimoto1, M Sakai, T Kajiyama, A Torii, S Ueda, Y Shimada, K Inoue, M Imamura, M Okuma.   

Abstract

Endoscopic variceal ligation is an effective therapy for variceal bleeding, and use of the method has recently been increasing. We evaluated the clinical usefulness of prophylactic endoscopic variceal ligation. Twenty-two patients with enlarged, tortuous varices and "red color signs" were selected. These patients were treated with ligation therapy alone and the varices were eradicated, i.e., reduced to small, straight varices without red color signs. Ligation therapy was withdrawn if the general condition of the patient worsened or if the varices could not be removed by suction. Follow-up endoscopy was performed every 4 months, and another ligation was performed if there were recurrent varices or variceal bleeding. The total reduction rate was 86.4%, and eradication required two sessions of therapy and 30 days of hospitalization on average. Complications included esophageal injury in 1 patient and treatment-induced bleeding in 1 patient; both complications were easily controlled. No variceal bleeding occurred after the eradication. There was no mortality due to gastrointestinal bleeding during the median follow-up period of 346 days. Prophylactic endoscopic variceal ligation made it possible to prevent fatal variceal bleeding with a minimum risk of complications, suggesting that this could be an alternative method for the prevention of first-time variceal bleeding.

Entities:  

Mesh:

Year:  1997        PMID: 9058288     DOI: 10.1007/bf01213289

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

1.  Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial.

Authors: 
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

2.  Improved survival after prophylactic portal nondecompression surgery for esophageal varices: a randomized clinical trial. Cooperative Study Group of Portal Hypertension of Japan.

Authors:  K Inokuchi
Journal:  Hepatology       Date:  1990-07       Impact factor: 17.425

3.  Venous complications of sclerotherapy for esophageal varices.

Authors:  G C Hunter; T Steinkirchner; E J Burbige; J M Guernsey; C W Putnam
Journal:  Am J Surg       Date:  1988-12       Impact factor: 2.565

4.  [Clinical evaluation of endoscopic variceal ligation (EVL)].

Authors:  H Kishimoto; M Sakai; T Kajiyama; A Torii; M Hosokawa; H Kajita; T Koizumi; H Tsukada; S Ueda; M Okuma
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1994-01

Review 5.  Prophylaxis of first variceal bleeding.

Authors:  G Kleber; H Ansari; T Sauerbruch
Journal:  Baillieres Clin Gastroenterol       Date:  1992-09

6.  Endoscopic ligation of esophageal varices.

Authors:  G Van Stiegmann; J S Goff; J H Sun; D Hruza; R M Reveille
Journal:  Am J Surg       Date:  1990-01       Impact factor: 2.565

7.  End point for sclerosis of esophageal varices.

Authors:  B K Agrawal; A Suman; V Singh; P Kumar
Journal:  Indian J Gastroenterol       Date:  1993-07

8.  Is there an indication for prophylactic endoscopic paravariceal injection sclerotherapy in patients with liver cirrhosis and portal hypertension?

Authors:  K J Paquet; P Koussouris
Journal:  Endoscopy       Date:  1986-05       Impact factor: 10.093

9.  A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices.

Authors:  J M Fardy; A Laupacis
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

10.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

Authors:  K J Paquet
Journal:  Endoscopy       Date:  1982-01       Impact factor: 10.093

View more
  1 in total

1.  Esophageal Capsule Endoscopy for Screening Esophageal Varices among Japanese Patients with Liver Cirrhosis.

Authors:  Haruya Ishiguro; Shoichi Saito; Hiroo Imazu; Hiroyuki Aihara; Tomohiro Kato; Hisao Tajiri
Journal:  Gastroenterol Res Pract       Date:  2011-11-30       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.